Your browser is no longer supported. Please, upgrade your browser.
Settings
EOLS Evolus, Inc. daily Stock Chart
EOLS [NASD]
Evolus, Inc.
Index- P/E- EPS (ttm)-3.41 Insider Own1.60% Shs Outstand33.72M Perf Week-42.48%
Market Cap97.74M Forward P/E- EPS next Y-0.85 Insider Trans0.00% Shs Float22.31M Perf Month-36.12%
Income-98.80M PEG- EPS next Q-0.70 Inst Own43.50% Short Float24.54% Perf Quarter-26.79%
Sales45.40M P/S2.15 EPS this Y-66.00% Inst Trans0.09% Short Ratio4.97 Perf Half Y-71.82%
Book/sh1.86 P/B1.65 EPS next Y69.50% ROA-47.00% Target Price- Perf Year-80.50%
Cash/sh3.12 P/C0.98 EPS next 5Y16.80% ROE-197.30% 52W Range3.00 - 20.27 Perf YTD-74.86%
Dividend- P/FCF- EPS past 5Y- ROI-49.10% 52W High-84.90% Beta-
Dividend %- Quick Ratio5.00 Sales past 5Y- Gross Margin73.10% 52W Low2.00% ATR0.55
Employees220 Current Ratio5.60 Sales Q/Q- Oper. Margin- RSI (14)30.00 Volatility14.41% 9.95%
OptionableYes Debt/Eq1.47 EPS Q/Q-45.70% Profit Margin- Rel Volume0.87 Prev Close3.20
ShortableYes LT Debt/Eq1.47 Earnings- Payout- Avg Volume1.10M Price3.06
Recom2.10 SMA20-38.79% SMA50-35.24% SMA200-66.23% Volume961,941 Change-4.38%
Jul-07-20Downgrade Mizuho Buy → Neutral $8 → $3
Feb-06-20Resumed Mizuho Buy
Nov-26-19Initiated SVB Leerink Outperform $25
Sep-05-19Resumed Mizuho Buy $30
Jun-28-19Initiated Wells Fargo Market Perform $16
Jun-11-19Initiated Barclays Underweight $13
Mar-20-19Initiated SunTrust Buy $30
Feb-14-19Initiated H.C. Wainwright Buy $37
Jan-29-19Initiated Stifel Buy $27
Jul-08-20 01:39PM  
01:32PM  
Jul-07-20 09:10AM  
08:17AM  
Jul-06-20 07:48PM  
07:45PM  
Jul-01-20 11:29PM  
May-25-20 05:40AM  
May-14-20 09:50AM  
May-12-20 05:00AM  
May-11-20 04:01PM  
May-06-20 04:01PM  
Apr-16-20 04:52PM  
Apr-05-20 09:55AM  
Mar-04-20 09:08AM  
Mar-03-20 09:00AM  
Feb-28-20 08:43AM  
Feb-25-20 07:00AM  
06:00AM  
Feb-13-20 08:30AM  
Feb-12-20 08:30AM  
Jan-27-20 11:17AM  
09:00AM  
Jan-09-20 09:00AM  
Jan-06-20 06:25AM  
Dec-17-19 04:38PM  
Nov-07-19 04:10PM  
06:50AM  
01:18AM  
Nov-06-19 04:02PM  
Nov-04-19 07:00AM  
Oct-31-19 02:13PM  
Oct-28-19 04:05PM  
Oct-16-19 09:05AM  
Oct-15-19 05:04PM  
Oct-01-19 09:09AM  
Sep-27-19 07:14AM  
Sep-18-19 09:00AM  
Sep-04-19 06:00AM  
Aug-22-19 04:05PM  
Aug-20-19 11:20AM  
Aug-13-19 08:02AM  
Aug-12-19 11:23AM  
07:59AM  
07:01AM  
07:01AM  
06:00AM  
Aug-09-19 07:36AM  
Aug-08-19 07:03AM  
06:39AM  
Aug-01-19 08:30AM  
Jul-30-19 10:22AM  
Jul-15-19 08:30AM  
Jul-12-19 08:39AM  
Jul-10-19 07:09AM  
Jul-08-19 09:41AM  
Jul-01-19 12:49PM  
12:46PM  
Jun-28-19 03:16PM  
Jun-25-19 11:39AM  
09:48AM  
09:34AM  
09:10AM  
Jun-10-19 09:00AM  
Jun-05-19 07:45AM  
May-28-19 04:01PM  
May-21-19 09:00AM  
May-15-19 04:58PM  
09:00AM  
May-08-19 03:17PM  
May-06-19 01:32PM  
May-01-19 10:38AM  
Apr-30-19 10:27PM  
04:01PM  
Apr-29-19 08:00AM  
Apr-28-19 11:19PM  
Apr-26-19 11:14AM  
08:50AM  
Apr-25-19 12:02PM  
11:38AM  
11:08AM  
10:39AM  
Apr-24-19 04:05PM  
10:01AM  
Apr-23-19 10:41AM  
Apr-08-19 07:00AM  
Apr-03-19 08:16AM  
Apr-01-19 09:00AM  
Mar-25-19 04:35PM  
Mar-21-19 08:19AM  
08:00AM  
Mar-20-19 03:25PM  
Mar-19-19 01:17PM  
Mar-18-19 04:04PM  
04:01PM  
Mar-15-19 04:01PM  
Mar-12-19 01:23PM  
Mar-06-19 08:54AM  
Feb-27-19 09:00AM  
Feb-21-19 09:47AM  
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was founded in 2012 and is headquartered in Newport Beach, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Avelar RuiSee RemarksJan 07Sale10.7139,442422,28270,802Jan 08 07:37 PM
Avelar RuiSee RemarksDec 10Option Exercise9.9810,020100,000110,244Dec 11 05:53 PM